Login Sign Up Contact Us
Countries

Categories

Bivalirudin Trifluoroacetate

TypeName: Business Offer
Request Date:2017/06/23
Country: United States
Summary: BG 8967; Hirulog; Hirulog I; Bivalirudin; Angiomax; Hirulog-1; Hirulog1; Hirulog 1; BG8967; BG 8967; BG-8967; LS-172701; LS172701; LS 172701
Description: Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors. It is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin. Bivalirudin inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation. It has a quick onset of action and a short half-life, without binding to plasma proteins (other than thrombin) or red blood cells. Therefore it has a predictable antithrombotic response.http://www.creative-peptides.com/product/bivalirudin-trifluoroacetate-item-10-101-06-16.html
Advantages:
Comments:
RequestId: 275
Name:Cathy Miller
Telphone:
Email:contact@creative-peptides.com

Special Business
Paradise Tree Surgeons and Landscaping
San Diego Criminal Attorney
Law Offices of Sotera L. Anderson
Supfort Web Design, SEO, and Development
Christensen Financial Inc.
Skyline Chicago Limo
United States